PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Scharfetter J. Neuropsychiatr. Jan 2014; 28(1): 1-5 Pubmed [3730]
Scharton D. Antiviral Res. Apr 2014; 104: 84-92 Pubmed, Volltext, DOI [8618]
Scheen AJ. Clin Pharmacokinet. Apr 2014; 53(4): 295-304 Pubmed [5773]
Scheen AJ. Clin Pharmacokinet. Jan 2007; 46(1): 1-12 Pubmed [2908]
Scheen AJ. Clin Pharmacokinet. Jan 2007; 46(2): 93-108 Pubmed [165]
Scheen AJ. Clin Pharmacokinet. Sep 2010; 49(9): 573-88 Pubmed [5776]
Scheen AJ. Expert Opin Biol Ther. Apr 2017; 17(4): 485-496 Pubmed [9008]
Scheen AJ. Lancet. Nov 2006; 368(9548): 1660-72 Pubmed [2628]
Scheibner AC. Prog Transplant. Sep 2021; 31(3): 236-241 Pubmed [12623]
Schellander R. Pharmacology. Jan 2010; 86(4): 203-15 Pubmed [3162]
Schelleman H. Br J Clin Pharmacol. Sep 2014; 78(3): 639-48 Pubmed [12298]
Schelleman H. Clin Pharmacol Ther. Aug 2010; 88(2): 214-22 Pubmed, Volltext, Nature [5931]
Schelleman H. Clin Pharmacol Ther. Nov 2008; 84(5): 581-8 Pubmed, Volltext, Nature [5901]
Schelleman H. PLoS One. Jan 2011; 6(6): e21447 Pubmed, Volltext, DOI [4773]
Scherf-Clavel M. Pharmacopsychiatry. Jan 2020; 53(1): 30-35 Pubmed [9125]
Scheschonka A. Pain. Jul 2003; 104(1-2): 423-4 Pubmed [11295]
Schier AR. Braz J Psychiatry. Jun 2012; 34 Suppl 1: S104-10 Pubmed [11689]
Schiff PL. Am J Pharm Educ. Oct 2006; 70(5): 98 Pubmed [12845]
Schijvens AM. Pediatr Nephrol. Mar 2019; 34(3): 389-403 Pubmed, Volltext, Springer [9100]
Schillevoort I. Eur J Clin Pharmacol. Jul 2001; 57(4): 327-31 Pubmed [1548]
Schillevoort I. Int Clin Psychopharmacol. Mar 2002; 17(2): 75-9 Pubmed [10163]
Schilling U. Clin Drug Investig. Aug 2021; 41(8): 711-721 Pubmed [12708]
Schimpf R. Heart Rhythm. May 2012; 9(5): 776-81 Pubmed, Volltext, DOI [9250]
Schippers EF. AIDS. Dec 2000; 14(17): 2794-5 Pubmed [7060]
Schjerning O. Pharmacopsychiatry. Jan 2015; 48(1): 15-8 Pubmed [9480]
Schlatter J. Presse Med. Sep 1999; 28(25): 1381-4 Pubmed [6089]
Schlienger R. Eur Neuropsychopharmacol. May 2000; 10(3): 219-21 Pubmed [9196]
Schlienger RG. Ann Pharmacother. Dec 2000; 34(12): 1402-5 Pubmed [2768]
Schlienger RG. Praxis (Bern 1994). Oct 1996; 85(44): 1407-12 Pubmed [5727]
Schlit AF. Pharmacol Res Perspect. Apr 2017; 5(3): e00309 Pubmed, Volltext, DOI [10420]
Schloss JM. Clin Nutr. Dec 2013; 32(6): 888-93 Pubmed [11553]
Schmider J. Biopharm Drug Dispos. Apr 1997; 18(3): 227-40 Pubmed [4506]
Schmider J. J Clin Pharmacol. Mar 1997; 37(3): 193-200 Pubmed [8264]
Schmider J. J Clin Psychopharmacol. Aug 1996; 16(4): 267-72 Pubmed [11924]
Schmidt A. Neuropsychiatr. Dec 2017; 31(4): 172-175 Pubmed [5357]
Schmidt D, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde. Nov 2007; 26(11): 969-980 Pubmed [9740]
Schmidt D, Steinhoff BJ, Stefan H, Elger CE, Pregabalin: An efficacious new add-on drug for chronic partial epilepsy, Nervenheilkunde. Vol. 23(8), (pp 471-477), 2004 [2580]
Schmidt D. J Neurol. Jun 1975; 209(2): 115-23 Pubmed [9272]
Schmidt D. Nervenarzt. Oct 2000; 71(10): 849-55 Pubmed [2943]
Schmidt et al. Nervenheilkunde. Vol. 23(8), (pp 471-477), 2004 [2550]
Schmidt GA. J Am Board Fam Med. Jul 2007; 20(4): 411-6 Pubmed [4216]
Schmidt H. Int J Clin Pharmacol Ther. Mar 2003; 41(3): 95-106 Pubmed [11087]
Schmidt LG. Prog Neuropsychopharmacol Biol Psychiatry. Feb 2002; 26(2): 209-17 Pubmed [5567]
Schmidt-Kraepelin C. Lancet Psychiatry. Apr 2022; 9(4): 291-306 Pubmed [12437]
Schmitt C. Clin Pharmacol Ther. May 2011; 89(5): 735-40 Pubmed [8516]
Schmitt C. Pharmacotherapy. Oct 2009; 29(10): 1175-81 Pubmed [12970]
Schmutz JL. Ann Dermatol Venereol. Mar 2003; 130(3): 391 Pubmed [5246]
Schneck C. J Clin Psychiatry. Dec 1998; 59(12): 689 Pubmed [2293]
Schneider B. Pharmacopsychiatry. Mar 2004; 37(2): 43-5 Pubmed [7991]
Schneider C. Travel Med Infect Dis. Mar 2013; 11(2): 71-80 Pubmed [5112]
Schneider J. Schmerz. Apr 2019; 33(2): 165-179 Pubmed [8467]
Schneider KL. Front Pharmacol. Jan 2020; 10: 1620 Pubmed, Volltext, DOI [9199]
Schneider RA. Am J Health Syst Pharm. Nov 2008; 65(22): 2122-5 Pubmed [9840]
Schneider U. Addict Biol. Jan 2000; 5(1): 65-9 Pubmed [11445]
Schoedel KA. Clin Drug Investig. Mar 2012; 32(3): 157-69 Pubmed [2017]
Schoenenberger JA. Ther Drug Monit. Feb 2013; 35(1): 71-7 Pubmed [8391]
Schoenfelder Y. J Neuroendocrinol. May 2012; 24(5): 809-17 Pubmed [12999]
Schoenholtz N Engl J Med 2005 Jan 20;352(3):301-4 [3081]
Schoerlin MP. Clin Pharmacol Ther. Jan 1991; 49(1): 32-8 Pubmed [1915]
Schoffelen R. Neth J Med. Apr 2018; 76(3): 109-114 Pubmed [11994]
Schofield C. Neurodegener Dis Manag. Apr 2022; 12(2): 77-91 Pubmed [12190]
Schöller-Gyüre M. Br J Clin Pharmacol. Oct 2008; 66(4): 508-16 Pubmed, Volltext, DOI [6613]
Schöller-Gyüre M. Clin Pharmacokinet. Jan 2009; 48(9): 561-74 Pubmed [7409]
Schöller-Gyüre M. Contraception. Jul 2009; 80(1): 44-52 Pubmed [6612]
Schöller-Gyüre M. J Clin Pharmacol. Feb 2013; 53(2): 202-10 Pubmed [6272]
Schöller-Gyüre M. J Clin Pharmacol. Mar 2008; 48(3): 322-9 Pubmed [3410]
Scholten JN. Clin Infect Dis. Dec 2003; 37(12): 1686-92 Pubmed [6802]
Scholten PC. Antimicrob Agents Chemother. Dec 1998; 42(12): 3266-8 Pubmed, Volltext [6996]
Scholz EP. Naunyn Schmiedebergs Arch Pharmacol. Nov 2003; 368(5): 404-14 Pubmed [9396]
Schonder KS. Ann Pharmacother. Dec 2003; 37(12): 1793-6 Pubmed [6451]
Schönfelder S. Clin Neuropharmacol. Nov 2011; 34(6): 256-7 Pubmed [2743]
Schönfeldt-Lecuona C. Pharmacopsychiatry. Jul 2006; 39(4): 152-4 Pubmed [12787]
Schönfeldt-Leucona et al (2006) Pharmacopsychiatry 39:152-154 [2009]
Schoretsanitis G. CNS Drugs. Nov 2019 Pubmed [8161]
Schoretsanitis G. J Clin Psychopharmacol. Dec 2016; 36(6): 554-561 Pubmed [4336]
Schoretsanitis G. J Clin Psychopharmacol. May 2020; 40(3): 308-310 Pubmed [13766]
Schoretsanitis G. JAMA Netw Open. Aug 2024; 7(8): e2423385 Pubmed [13862]
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De [2070]
Schotte A. Psychopharmacology (Berl). Mar 1996; 124(1-2): 57-73 Pubmed [2071]
Schrantee A. J Cardiovasc Electrophysiol. Aug 2017; 28(8): 912-916 Pubmed [7537]
Schrezenmeier E. Nat Rev Rheumatol. Mar 2020; 16(3): 155-166 Pubmed [8902]
Schroder et al. J Pharmacol Exp Ther. 2011 Jan 24 [3156]
Schrold J. Psychopharmacologia. Jan 1972; 23(2): 115-24 Pubmed [6913]
Schroth W. Front Pharmacol. Aug 2017; 8: 582 Pubmed [11222]
Schrøder H. Pediatr Hematol Oncol. Jul 1994; 11(4): 445-9 Pubmed [2449]
Schuetz EG. Proc Natl Acad Sci U S A. Apr 1996; 93(9): 4001-5 Pubmed [13723]
Schuetze K. Injury. Nov 2019; 50(11): 2040-2044 Pubmed [8224]
Schulman S. Ann Pharmacother. Jan 2002; 36(1): 72-4 Pubmed [8638]
Schultze-Mosgau MH. Hum Reprod. Aug 2016; 31(8): 1713-22 Pubmed [7692]
Schulz-Du Bois C. Pharmacopsychiatry. Nov 2008; 41(6): 258-9 Pubmed [6990]
Schulz, E., Koch, K. Schmidt, F.H. European Journal of Pharmacology. Dec 1971 Pubmed [12812]
Schumacher JD. Toxicol Appl Pharmacol. Nov 2015; 289(1): 40-7 Pubmed, Volltext, DOI [5273]
Schürks M. Pharmacopsychiatry. Mar 2005; 38(2): 100-2 Pubmed [2894]
Schussler JM. Am J Psychiatry. Mar 2003; 160(3): 589 Pubmed [4806]
Schuster R. Eur Addict Res. Jan 2021; 27(5): 332-340 Pubmed [13819]
Schutgens RE. Hemasphere. Dec 2020; 5(1): e526 Pubmed [12022]
Schütz SG. HIV AIDS (Auckl). Sep 2013; 5: 243-51 Pubmed, Volltext, DOI [3807]
Schwab et al. Deutsches Ärzteblatt Jg. 99/Heft 8/22. Februar 2002 [3061]
Schwab M et al, Pharmakogenetik der Zytochrom-P-450-Enzyme,Bedeutung für Wirkungen und Nebenwirkungen von Medikamenten, Deutsches Ärzteblatt,Heft,22.Februar 2002: A 497-504 [3764]
Schwab M et al. Pharmakogenetik der Zytochrom-P-450-Enzyme Dtsch Arztebl 2002; 99: A 497–504 [Heft 8] [3797]